Abstract & Article Details
Letter to Editor • Vol.1, Issue 7 • ISSN: 2766-2276 • Open Access • CC BY 4.0
Open Access
Letter to Editor
Vol.1, Issue 7 November 18, 2020
Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections
DOI:
10.37871/jbres1160
Abstract
Dr. Ansovini began studying viruses by focusing his attention on HIV-1. The main discovery he made is that this virus, so difficult to treat, can be classified as “electricalâ€: one of its functional proteins, i.e. “p. 24â€, actually has an electrical value, in other words it has a charge, and therefore it is not allosterically neutral as proteins usually are.
Research Topics
Get email alerts when new articles are published in these topics
Subscribe for Alerts
How to Cite
Raffaele Ansovini* and Leonardo Compagnucci (2020). Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections. Journal of Biomedical Research & Environmental Sciences, 1(7). https://doi.org/10.37871/jbres1160
Article Information
| Journal | Journal of Biomedical Research & Environmental Sciences (JBRES) |
|---|---|
| ISSN | 2766-2276 |
| DOI | DOI 10.37871/jbres1160 |
| Volume / Issue | Vol. 1, Issue 7 |
| Received | November 16, 2020 |
| Accepted | November 17, 2020 |
| Published | November 18, 2020 |
| Article Type | Letter to Editor |
| Pages | 311-312 |
| License | CC BY 4.0 — Open Access |
| Publisher | SciRes Literature LLC, Sheridan, WY, USA |
| Language | English |
Published under CC BY 4.0 — free to share, copy, adapt, and redistribute with attribution.
Certificate of Publication
Certificate verifies that this article was peer-reviewed and published in the Journal of Biomedical Research & Environmental Sciences.